Stefano Turchetta
29Patents
5h-index
25Co-inventors
69Inventor score
Filing activity: Mar 7, 1996 → Mar 5, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7884136B2 | Modified-release formulations of a bupropion salt | Chemistry; Metallurgy | 131 | Active |
| US7579380B2 | Modified release formulations of a bupropion salt | Chemistry; Metallurgy | 127 | Active |
| US7241805B2 | Modified release formulations of a bupropion salt | Chemistry; Metallurgy | 44 | Active |
| US6897339B2 | Process for the production of high purity iohexol | Chemistry; Metallurgy | 14 | Expired |
| US7332603B2 | Preparation of biphosphonic acids and salts thereof | Chemistry; Metallurgy | 13 | Expired |
| US7553992B2 | Modified release formulations of a bupropion salt | Chemistry; Metallurgy | 5 | Active |
| US7417149B2 | Process for the preparation of Montelukast | Chemistry; Metallurgy | 4 | Expired |
| US5756737A | Process for the preparation of 9-(2-hydroxy)-ethoxymethyl-guanine | Chemistry; Metallurgy | 4 | Expired |
| US7572935B2 | Modified release formulations of a bupropion salt | Chemistry; Metallurgy | 4 | Active |
| US7645901B2 | Modified release formulations of a bupropion salt | Chemistry; Metallurgy | 3 | Active |
| US7358399B2 | Process for the preparation of N,N-diisopropyl-3-(2-hydroxy-5-methylphenyl)-3-phenyl-propaneamine | Emerging Cross-Sectional Technologies | 2 | Expired |
| US8232392B2 | Process for preparing temozolomide | Chemistry; Metallurgy | 2 | Active |
| US6583287B1 | Process for the production of paroxetine | Human Necessities | 2 | Expired |
| US8349900B2 | Bupropion hydrobromide polymorphs | Chemistry; Metallurgy | 1 | Active |
| US8049031B2 | Solid forms of fesoterodine fumarate | Chemistry; Metallurgy | 1 | Active |
| US8518988B2 | Polymorph of the hydrochloride of the (4-hydroxycarbamoyl-phenyl)-carbamic acid (6-dimethylamino methyl-2-naphthalenyl) ester | Human Necessities | 1 | Active |
| US8445716B2 | Method for preparing fesoterodine and/or fesoterodine fumarate | Chemistry; Metallurgy | 0 | Active |
| US12129224B2 | Process for preparing {6-[(diethylamino)methyl]naphthalen-2-yl}methyl [4-(hydroxycarbamoyl)phenyl]carbamate having high purity | Physics | 0 | Active |
| US9308174B2 | Lyophilized formulations of bendamustine hydrochloride | Human Necessities | 0 | Active |
| US8946456B2 | Process for the preparation of 2-hydroxy-4-phenyl-3,4-dihydro-2H-chromen-6-yl-methanol and (R)-feso-deacyl | Chemistry; Metallurgy | 0 | Active |
| US9266863B2 | Process for the synthesis of azacitidine and decitabine | Chemistry; Metallurgy | 0 | Active |
| US9206229B2 | Bortezomib esters and formulations thereof | Chemistry; Metallurgy | 0 | Active |
| US9096491B2 | Prodrug of an anti-inflammatory active ingredient | Chemistry; Metallurgy | 0 | Active |
| US9272982B2 | Method for preparing high-purity fesoterodine fumarate | Chemistry; Metallurgy | 0 | Active |
| US7858634B2 | Amorphous 3-pyridil-1-hydroxyethyliden-1,1-biphosphonic acid monosodium salt and process for the preparation thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.